Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Essilor International
Age
6–12
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Equal to or greater than 6 years and not older than 12 years at time of informed consent and assent.
Spherical equivalent refractive error (SER) by manifest refraction between -0.75 and -4.50 D in each eye.
Astigmatism, if present, of not more than 1.50 D.
Difference in SER between the two eyes (Anisometropia) by manifest refraction not more than 1.00 D.
Best corrected visual acuity in each eye equal to or better than +0.10 logMAR (≥ 20/25 as Snellen)
Agree to wear spectacles for ≥10 hours/day at least 6 days/week.
Willingness and ability to participate in trial for 3 years and attend scheduled visits.
You may not be if
History of myopia control intervention (e.g., atropine, orthokeratology, multifocal contact lenses, etc.)
Strabismus by cover test at near or distance wearing correction.
Amblyopia
Any ocular or systemic condition known to affect refractive status (e.g., keratoconus, diabetes, Down's syndrome, etc.).
Current use of ocular or systemic medications which, in the investigator's opinion, may significantly affect pupil size, accommodation or refractive state.
Current or anticipated use of growth hormones.
Participation in any clinical study within 30 days of the Baseline visit.
Clareo Health | Myopia Control With a Innovative Spectacle Lens
